中信证券研报表示，2025年11月中国社零总额43,898亿元/同比+1.3%，低于Wind一致预期的+2.9%，限 额以上商品零售总额16,430亿元/同比-2.2%，剔除汽车、石油类限额以上零售额增速+1.8%。汽车高基 数叠加补贴退坡导致降幅走阔；粮油食品表现良好，日用品增速转负；低基数下可选表现平稳，国补品 类有所拖累；服务消费、餐饮收入稳健。11月社零读数低于预期，表明当前内需仍有待提振，商品销售 在补贴退坡后渐显疲弱。近期中共中央政治局会议、中央经济工作会议继续强调扩大内需的必要性，我 们认为，由于当前宏观环境仍然偏弱，消费景气的自身修复预计仍需时间，短期消费整体beta性机会可 关注财政刺激类政策的可能性。同时，基于当前产业观察，2026年建议重点关注财富效应传导、供给端 优化推动的经营拐点机会。而长期配置再次强调重视消费结构的变化。 （文章来源：第一财经） ...

免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 每经头条（nbdtoutiao）——中标企业频频弃标 大型医疗设备采购有何难言之隐？ （记者 曾健辉） 每经AI快讯，中信证券（SH 600030，收盘价：28.48元）12月16日晚间发布公告称，截至公告披露日， 公司及控股子公司对外担保总额为人民币2100.35亿元，占公司最近一期经审计净资产的比例为 71.66%。 2025年1至6月份，中信证券的营业收入构成为：证券投资业务占比43.88%，经纪业务占比28.21%，资 产管理业务占比18.21%，投资银行业务占比6.22%，其他业务占比3.49%。 截至发稿，中信证券市值为4221亿元。 ...

本次发行后，发行人在中票计划下已发行票据的本金余额合计28.64亿美元。 中信证券（600030）(06030)发布公告，公司境外全资子公司中信证券国际有限公司(中信证券国际)的附 属公司CSI MTN Limited(发行人或被担保人)于2022年3月29日设立境外中期票据计划(中票计划)，此中 票计划由中信证券国际提供担保。根据存续票据到期情况，结合公司业务发展实际需要，发行人于2025 年12月15日、 16日在中票计划下发行两笔票据，发行金额1.4亿美元和1.8亿港币。 ...

重要内容提示： 证券代码：600030 证券简称：中信证券 公告编号：临2025-097 中信证券股份有限公司 关于间接子公司发行中期票据 并由全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 担保对象及基本情况 | | 被担保人名称 本次担保金额 | CSI Limited | MTN | | | --- | --- | --- | --- | --- | | | | 1.4亿美元和1.8亿港币 | | | | 担保对象 | 实际为其提供的担保余额 | 28.64亿美元 | | | | | 是否在前期预计额度内 | 是 | □否 | □不适用 | | | 本次担保是否有反担保 | □是 | 否 | □不适用 | 累计担保情况 | 对外担保逾期的累计金额（万元） | - | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（亿元） | 2,100.35 | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 71.66 | | 特别风险提示 | □对外担 ...

智通财经APP讯，中信证券(06030)发布公告，公司境外全资子公司中信证券国际有限公司(中信证券国 际)的附属公司CSI MTN Limited(发行人或被担保人)于2022年3月29日设立境外中期票据计划(中票计 划)，此中票计划由中信证券国际提供担保。根据存续票据到期情况，结合公司业务发展实际需要，发 行人于2025年12月15日、 16日在中票计划下发行两笔票据，发行金额1.4亿美元和1.8亿港币。 本次发行后，发行人在中票计划下已发行票据的本金余额合计28.64亿美元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任 何責任。 （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） （股份代號：6030） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中信証券股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司關於間 接子公司發行中期票據並由全資子公司提供擔保的公告，僅供參閱。 承董事會命 中信証券股份有限公司 董事長 張佑君 中國北京 2025年12月16日 於本公告刊發日期 ，本公司執行董事為張佑君先生及鄒迎光先生；本公司非執行董事為張麟先生 、付臨芳女士 、 趙先信先生及王恕慧先生；及本公司獨立非執行董事為李青先生、史青春先生及張健華先生。 证券代码：600030 证券简称：中信证券 公告编号：临2025-097 中信证券股份有限公司 关于间接子公司发行中期票据 并由全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 ...

Group 1 - The stock price of Jindike (688670.SH) fell by 7.02%, closing at 22.26 yuan, indicating it is currently in a state of decline since its IPO [1] - Jindike was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on August 2, 2021, with an initial public offering (IPO) of 22 million shares at a price of 55.18 yuan per share [1] - The total amount raised from the IPO was 1.214 billion yuan, with a net amount of 1.136 billion yuan, which is 464 million yuan less than the originally planned net amount of 1.6 billion yuan [1] Group 2 - The company initially intended to raise 1.6 billion yuan for projects including the construction of a new facility for a quadrivalent influenza virus vaccine, innovative vaccine research and development, working capital, and repayment of bank loans [1] - The total issuance costs for the IPO amounted to 78.2839 million yuan, with underwriting and sponsorship fees accounting for 64.3399 million yuan [1] - Citic Securities' subsidiary, Citic Securities Investment Co., Ltd., participated in the investment with a stake of 4%, acquiring 880,000 shares for 48.5584 million yuan, with a lock-up period of 24 months [1] Group 3 - On May 19, 2023, Jindike announced its 2022 annual profit distribution plan, which included a cash dividend of 0.2 yuan per share and a capital reserve increase of 0.4 shares per share [2] - The total cash dividend distributed amounted to 17.6 million yuan, and the share capital increase resulted in an additional 35.2 million shares, bringing the total share capital to 123.2 million shares [2] - Key dates for the distribution included the equity registration date on May 25, 2023, the ex-dividend date on May 26, 2023, and the cash dividend payment date also on May 26, 2023 [2]

Group 1 - The stock price of CanSino Biologics (688185.SH) fell by 2.56% to 62.84 yuan, indicating it is currently in a state of decline since its IPO [1] - CanSino was listed on the Shanghai Stock Exchange's STAR Market on August 13, 2020, with an initial issuance of 24.8 million shares at a price of 209.71 yuan per share [1] - The total funds raised from the IPO amounted to 5.201 billion yuan, with a net amount of 4.979 billion yuan after deducting issuance costs, which was 3.979 billion yuan more than the original plan of 1 billion yuan [1] Group 2 - The issuance costs for CanSino's IPO were 221 million yuan, with underwriting and sponsorship fees accounting for 205 million yuan [2] - CITIC Securities, as the lead underwriter, received an allocation of 496,000 shares, representing 2% of the total shares issued, with an investment amount of 104 million yuan [2]

Core Viewpoint - CITIC Securities initiates coverage on Zhenkunhang (ZKH.US) with a "Buy" rating and a target price of $4.3, highlighting its position as a leading MRO e-commerce platform in China, which is expected to return to a growth trajectory due to customer expansion and accelerated overseas business layout [1][2]. Group 1: Financial Performance - Zhenkunhang reported Q3 2025 revenue of 2.328 billion yuan, a year-on-year increase of 2.1%, with a Non-GAAP adjusted net loss of 14 million yuan, narrowing the loss by 78.7% year-on-year [1]. - After adjustments in the first half of the year, the company's business entered a recovery phase in Q3, with a reduced year-on-year decline in GMV and growth in total transaction volume from both large enterprises and SMEs [1]. Group 2: Strategic Initiatives - The company is committed to a private label strategy, with Q3 2025 private label GMV increasing by 16.7%, accounting for 8.2% of total GMV [1]. - The total number of customers reached 70,800 by Q3 2025, representing a 48.0% year-on-year increase, while over 2.3 million new SKUs were added, bringing the total available SKUs to over 19 million [1]. Group 3: AI and International Expansion - The company applies AI technology across various operational aspects, with the "AI Product Recommendation Brain" set to launch in Q4 2024, having already recommended over 20 million items and generating over 100 million yuan in incremental revenue by Q3 2025 [2]. - Zhenkunhang has expanded its distribution channels in the U.S., successfully entering third-party platforms like Amazon in addition to its own North American platform, Northsky [2].

Core Viewpoint - CITIC Securities has shown a mixed performance in financing activities, with a notable decrease in net financing buy and a significant increase in operating revenue and net profit year-on-year. Financing Activities - On December 15, CITIC Securities recorded a financing buy of 401 million yuan and a financing repayment of 590 million yuan, resulting in a net financing buy of -189 million yuan [1] - As of December 15, the total financing and securities lending balance was 18.463 billion yuan, with the financing balance at 18.440 billion yuan, accounting for 5.30% of the circulating market value, which is above the 80th percentile level over the past year [1] - In terms of securities lending, CITIC Securities repaid 66,800 shares and sold 171,000 shares on December 15, with a selling amount of 4.882 million yuan, while the securities lending balance was 22.8325 million yuan, below the 50th percentile level over the past year [1] Financial Performance - For the period from January to September 2025, CITIC Securities achieved an operating revenue of 55.815 billion yuan, representing a year-on-year growth of 20.96%, and a net profit attributable to shareholders of 23.159 billion yuan, with a year-on-year increase of 37.86% [2] Shareholder Information - As of September 30, 2025, CITIC Securities had 669,400 shareholders, an increase of 1.64% from the previous period, with an average of 18,192 circulating shares per person, a decrease of 1.61% [2] - Since its A-share listing, CITIC Securities has distributed a total of 88.704 billion yuan in dividends, with 22.009 billion yuan distributed in the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest, holding 500.1 million shares, a decrease of 83.4469 million shares from the previous period [3]